This company listing is no longer active
3HC Stock Overview
Franchise Group, Inc. owns and operates franchised and franchisable businesses.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 1/6 |
Dividends | 2/6 |
Franchise Group, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$27.31 |
52 Week High | US$37.20 |
52 Week Low | US$20.80 |
Beta | 1.69 |
11 Month Change | 2.86% |
3 Month Change | 1.22% |
1 Year Change | -23.29% |
33 Year Change | 30.05% |
5 Year Change | n/a |
Change since IPO | 50.14% |
Recent News & Updates
Recent updates
Shareholder Returns
3HC | DE Specialty Retail | DE Market | |
---|---|---|---|
7D | 0.8% | -0.8% | 1.1% |
1Y | -23.3% | 18.4% | 13.5% |
Return vs Industry: 3HC underperformed the German Specialty Retail industry which returned -4.3% over the past year.
Return vs Market: 3HC underperformed the German Market which returned 2.5% over the past year.
Price Volatility
3HC volatility | |
---|---|
3HC Average Weekly Movement | 1.5% |
Specialty Retail Industry Average Movement | 5.7% |
Market Average Movement | 4.7% |
10% most volatile stocks in DE Market | 10.8% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 3HC has not had significant price volatility in the past 3 months.
Volatility Over Time: 3HC's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2010 | 11,406 | Brian Kahn | www.franchisegrp.com |
Franchise Group, Inc. owns and operates franchised and franchisable businesses. It operates through six segments: Vitamin Shoppe, Pet Supplies Plus, Badcock, American Freight, Buddy’s, and Sylvan. The Vitamin Shoppe segment operates as an omnichannel specialty retailer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products.
Franchise Group, Inc. Fundamentals Summary
3HC fundamental statistics | |
---|---|
Market cap | €966.87m |
Earnings (TTM) | -€266.20m |
Revenue (TTM) | €3.96b |
0.2x
P/S Ratio-3.6x
P/E RatioIs 3HC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
3HC income statement (TTM) | |
---|---|
Revenue | US$4.31b |
Cost of Revenue | US$2.59b |
Gross Profit | US$1.72b |
Other Expenses | US$2.01b |
Earnings | -US$289.50m |
Last Reported Earnings
Jul 01, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -8.23 |
Gross Margin | 39.81% |
Net Profit Margin | -6.72% |
Debt/Equity Ratio | 839.7% |
How did 3HC perform over the long term?
See historical performance and comparison